Bruce Thompson, Kincell Bio CEO
July 26, 2023 06:00 AM EDTUpdated July 27, 09:38 AM
Cell/Gene Tx
Manufacturing

Ex­clu­sive: Cell ther­a­py CD­MO Kin­cell launch­es, and the spin­out is val­ued at $66M, with CEO look­ing for carve-outs

Andrew Dunn

Senior Biopharma Correspondent

A small CD­MO called Kin­cell Bio launched Wednes­day, with its CEO hop­ing to fill a niche of­fer­ing cell ther­a­py man­u­fac­tur­ing for ear­ly-stage biotech star­tups. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times